Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
---|---|---|---|
6/30/2025 | $ -145.77M | $ 29.8M | -4.89 |
3/31/2025 | $ -138.43M | $ 19.26M | -7.19 |
12/31/2024 | $ -214.44M | $ 12.66M | -16.94 |
9/30/2024 | $ -234.35M | $ 4.61M | -50.89 |
6/30/2024 | $ -235.82M | $ 5.41M | -43.6 |
3/31/2024 | $ -254.22M | $ 6.08M | -41.81 |
12/31/2023 | $ -256.78M | $ 6.86M | -37.42 |
9/30/2023 | $ -250.77M | $ 9.81M | -25.57 |
6/30/2023 | $ -260.06M | $ 14.14M | -18.39 |
3/31/2023 | $ -250.44M | $ 19.88M | -12.6 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for REGENXBIO INC is calculated as follows: EBIT [ $ -94.37M ] / Int. Exp. [ $ 0 ]
(=) Int. Coverage [ 0 ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.37K |
---|---|
min | -25.49 |
max | 28.75 |
average | 2.15 |
median | 2.08 |
std | 8.46 |